TTP 22

CAS No. 329907-28-0

TTP 22( TTP 22 | TTP-22 | TTP22 )

Catalog No. M14092 CAS No. 329907-28-0

TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 67 In Stock
10MG 101 In Stock
25MG 210 In Stock
50MG 311 In Stock
100MG 462 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TTP 22
  • Note
    Research use only, not for human use.
  • Brief Description
    TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM.
  • Description
    TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM; shows selectivity for CK2 over JNK3, ROCK1, and MET(IC50> 10 uM).
  • In Vitro
    TTP 22 is a potent CK2 inhibitor, with an IC50 of 100 nM and a Ki of 40 nM. TTP 22 shows no effect on other kianses such as Jnk3, Rock1, Tie2, Ask1, Met and FGFR1 at 10 μM.
  • In Vivo
    ——
  • Synonyms
    TTP 22 | TTP-22 | TTP22
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    CK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    329907-28-0
  • Formula Weight
    330.42
  • Molecular Formula
    C16H14N2O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 100 mg/mL
  • SMILES
    O=C(O)CCSC1=C(C(C2=CC=C(C)C=C2)=CS3)C3=NC=N1
  • Chemical Name
    3-[[5-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]thio]-propanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Golub AG, et al. Eur J Med Chem. 2011 Mar;46(3): 870-6.
molnova catalog
related products
  • Casein kinase 1δ-IN-...

    Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.

  • CX-4945 sodium salt

    A potent, selective, orally bioavailable, ATP-competitive inhibitor of protein kinase CK2 with Ki of 0.38 nM, CK2α IC50 of 1 nM.

  • Longdaysin

    Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).